Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3859 ARTÍCULOS , VIENDO DEL 3751 AL 3765

Clinical neurophysiology for tremor: Common questions in clinical practice

Schwingenschuh P, Van der Stouwe M, Pandey S, Hirschbichler S, Panyakaew P, Kojovic M, Mukherjee A, Tijssen MA, Merchant SHI, Vial F; MDS Clinical neurophysiology Study group.

Parkinsonism Relat Disord. 2025 Jan;130:107196. doi: 10.1016/j.parkreldis.2024.107196. Epub 2024 Nov 23.

Deterioration of preexisting myoclonus following nifedipine use in parkinsonian syndrome: A case report

Yamada G, Toyoda T, Katada E, Matsukawa N.

eNeurologicalSci. 2024 Dec 15;38:100545. doi: 10.1016/j.ensci.2024.100545. eCollection 2025 Mar.

Biallelic ELOVL1 Variants Are Linked to Hypomyelinating Leukodystrophy, Movement Disorder, and Ichthyosis

Wong KM, Maroofian R, Meier K, Diegmann S, Tkemaladze T, Alvi JR, Tasharrofi B, Efthymiou S, Munchau A, Korenke GC, Almontashiri N, Eyaid W, Kashgari A, Alotaibi M, Gärtner J, Huppke B, Asadollahi M, Chikvinidze G, Keramatipour M, Sultan T, Thiele H, Nürnberg P, Gräler MH, Houlden H, Huppke P.

Mov Disord. 2025 Sep;40(9):1836-1850. doi: 10.1002/mds.30258. Epub 2025 Jul 1.

Long-Term Outcomes of Chenodeoxycholic Acid Therapy for Cerebrotendinous Xanthomatosis: A Nationwide Study on Prognostic Factors and Treatment Response

Zubarioglu T, Kadıoğlu-Yılmaz B, Köse E, Teke-Kısa P, Balcı MC, Yazıcı H, Özturk-Hişmi B, Akgün A, Kor D, Yıldız S, Kılıç-Yıldırım G, Soyuçen E, Akçalı A, Yıldız Y, Durmuş A, Güneş D, Soylu-Üstkoyuncu P, Kasapkara ÇS, Erdöl Ş, Göksoy E, Akar HT, Gümüş H, Ekmekçi AH, Eminoğlu FT, Arslan N, Hanağası HA, Canda E, Genç E, Özer I, Gündüz A, Kıykım E, Aktuğlu-Zeybek Ç.

J Inherit Metab Dis. 2025 Jul;48(4):e70069. doi: 10.1002/jimd.70069.

Polypharmacy-induced serotonin syndrome revealing underlying neurocognitive impairment and cervical myelopathy

Shah J, Parsons A, Pathuri S, Lieberman J, Hatten-Powell C.

BMJ Case Rep. 2025 Sep 25;18(9):e267753. doi: 10.1136/bcr-2025-267753.

Safety and Efficacy of the AMPA Receptor Antagonist Perampanel for Tremors: A Systematic Review

Manalo RVM, Dela Cruz JRC, Pasco PM.

Acta Med Philipp. 2025 Sep 15;59(13):74-81. doi: 10.47895/amp.vi0.11650. eCollection 2025.

Movement disorders associated with acetylcholinesterase inhibitors in Alzheimer's dementia: A systematic review

Rissardo JP, Caprara ALF.

Brain Circ. 2025 Mar 21;11(1):9-23. doi: 10.4103/bc.bc_134_24. eCollection 2025 Jan-Mar.

Involuntary movements in patients with impaired awareness: A comparative study of phenomenology and neurophysiological evaluation

Coelho P, Kauppila LA, Franco AC, Bentes C, Valadas A, Coelho M, Peralta AR.

Seizure. 2025 Nov;132:82-87. doi: 10.1016/j.seizure.2025.08.004. Epub 2025 Aug 7.

The First Report of Putaminal Cysts in the Familial Series of Dystonia Associated with Salla Disease-the Phenotype Expanded

Macken E, O'Connor A, Fanning N, Sweeney BJ, Olszewska DA.

Mov Disord Clin Pract. 2026 Mar;13(3):820-823. doi: 10.1002/mdc3.70392. Epub 2025 Oct 10.

Long-Term Efficacy of Bilateral Globus Pallidus Internus Deep Brain Stimulation in Myoclonus-Dystonia Associated with KCNN2 Gene Mutation: A Case Study

Stodulska O, Milanowski L, Koziorowski D, Mandat T, Szlufik S.

Int J Mol Sci. 2025 Aug 10;26(16):7736. doi: 10.3390/ijms26167736.

Insufficient effect of deep brain stimulation in a patient with KCNN2-associated myoclonus-dystonia

Pauly MG, Thomsen M, Tadic V, Busch H, Depienne C, Lohmann K, Klein C, Brüggemann N.

Parkinsonism Relat Disord. 2025 Feb;131:107260. doi: 10.1016/j.parkreldis.2025.107260. Epub 2025 Jan 2.

Myoclonus-Dystonia plus Syndrome in a Patient Carrying a Novel TCF20 Variant

Magistrelli L, Contaldi E, D'Alfonso S, Corrado L.

Mov Disord Clin Pract. 2025 Jan;12(1):105-107. doi: 10.1002/mdc3.14241. Epub 2024 Oct 25.

Sodium Oxybate-Treated Familial Myoclonus-Dystonia Syndrome Due to Novel SGCE Variant

Alghamdi MA, Hamad MH, Alghamdi I, Alghamdi G, Al-Jelaify M, Alshimemeri S, Hamed H, Adly N, Salih MA, Almontashiri NA, Bashiri FA.

Am J Med Genet A. 2025 May;197(5):e63964. doi: 10.1002/ajmg.a.63964. Epub 2024 Dec 20.

Expanding the Phenotypic Horizon of VAC14-Related Neurodegeneration

Chowdhury SR, Singh T, Meena R, Ganguly J, Sharma S.

Mov Disord Clin Pract. 2025 Oct;12(10):1664-1667. doi: 10.1002/mdc3.70127. Epub 2025 May 19.

Myoclonic status epilepticus with dystonia-like symptoms in patients with dementia: Report of two cases

Rossi RV, Melis R, Murdeu N, Lizzos S, Piras ML, Racis L, Serusi S, Saddi MV.

Epilepsy Behav Rep. 2025 Feb 4;29:100750. doi: 10.1016/j.ebr.2025.100750. eCollection 2025 Mar.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias